Dyadic’s C1 beats industry-standard antigen in Sanofi Pasteur trials
In Florida, Dyadic received the test results from the mice trials in a research program with Sanofi Pasteur indicating that the C1-produced antigen generated an equal, or better, immune response in mice than the industry standard antigen. At the same time, Dyadic joined the EU-funded Zoonoses Anticipation and Preparedness Initiative, a/k/a/ ZAPI, which aims to develop […]